Skytale Group vs Terri Ross Consulting

Sequence by problem, not prestige. If your consults aren't converting, revenue per patient is flat, or your team can't sell, start with Terri Ross Consulting—that's income-statement work, and it's what builds the EBITDA a future buyer pays for. If you're weighing an exit, fielding buyer interest, planning multi-site growth, or need to know what the practice is worth, start with Skytale. Many owners rationally use both over a practice's life: operator-led performance work first, institutional transaction advisory when the balance-sheet question arrives.

Differently verifiable, and that matters in a category where almost everything is self-reported. Skytale's medical-aesthetics deal record—MD Esthetics/New Harbor Capital, Blush Med Spa/AMP, Revitalize SkinMD/Empower Aesthetics, Synergy MedAesthetics—is confirmed by public transaction announcements. Terri Ross Consulting's headline figures, including 2,000+ practices trained, are company-reported, as is standard for training consultancies, and the founder's operator history (a Beverly Hills med spa grown to $4M and acquired by SkinSpirit) anchors the credibility. For either firm, still ask for references matched to your revenue stage.

Neither publishes pricing—both quote custom engagements, which is the norm across med spa consulting. Skytale's M&A work follows the retainer-plus-success-fee structure typical of investment-banking advisory, with consulting projects quoted to scope; scrutinize the success-fee terms, exclusivity, and tail before signing. Terri Ross offers multiple entry points—the APX software subscription and mastermind programs at the accessible end, dedicated consulting quoted to scope above them. Force identical written scope from any firms you compare, and see our pricing guide for how each engagement model works.

Not directly—it isn't an M&A or valuation firm, and that's fine, because its work is arguably the best pre-sale investment available. Practices trade on multiples of earnings, so the conversion, average-ticket, and retention gains a sales-and-ops consultancy drives flow straight into the EBITDA a buyer pays a multiple on. When you're ready to transact, you'll want a sell-side advisor: Skytale Group at the institutional and multi-site end, or a practice-level brokerage like Aesthetic Brokers, ideally anchored by an independent valuation.

Often, but not always. If you're years from any transaction and your challenges are conversion, staffing, and daily operations, an operator-led consultancy like Terri Ross—or ops firms like Shorr Solutions—will return more per dollar. Skytale becomes the right call earlier than many owners assume, though: if you're fielding unsolicited private-equity interest, weighing a second or third location, or within two to three years of a possible exit, institutional advice on valuation and readiness can change the outcome by far more than its fee. The wrong move is hiring neither and improvising a transaction.